Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03511586 · ClinicalTrials.gov registry record

Total Shoulder Arthroplasty Multi-Center Registry

A clinical trial of Shoulder Arthroplasty, sponsored by Arthrex.

Recruiting
Registry status
2,500
Enrollment target
20
Study locations

NCT03511586 is a study of Shoulder Arthroplasty that is actively recruiting participants, run by Arthrex. The registered enrollment target is 2,500 participants, above the 606-participant average among 5 other Shoulder Arthroplasty trials with a reported enrollment target (313% higher). The trial reports 20 study locations across 15 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03511586, a study of Shoulder Arthroplasty, is actively recruiting participants, sponsored by Arthrex.

RECRUITING
Registry status
2,500 participants
Enrollment target
20
Study locations

Study Summary

The objective of the study is a multi-center prospective registry to collect clinical outcomes of anatomic and reverse total shoulder arthroplasty.

Conditions Studied

Study Locations (20)

Arizona

  • University of Arizona/Banner Health - Phoenix
  • Banner Medical Group - Phoenix
  • - Scottsdale

Florida

  • Andrews Research & Education Foundation - Gulf Breeze
  • Advent Health Orlando - Orlando

Michigan

  • The University of Michigan - Ann Arbor
  • - Grand Rapids

North Carolina

  • University of North Carolina - Chapel Hill
  • Wake Forest University Health Sciences - Winston-Salem

Colorado

  • - Denver

Connecticut

  • University of Connecticut Health Center - Farmington

Illinois

  • NorthShore University Health System - Evanston

Indiana

  • The Trustees of Indiana University - Indianapolis

Trial Details

FieldValue
Enrollment Target 2,500 participants
Start Date 2015-07-28
Est. Completion 2035-11

Sponsor

Arthrex

12 total trials

What the Registry Record Tells You About NCT03511586

The ClinicalTrials.gov registry entry for NCT03511586 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 2,500 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 606-participant average among 5 other Shoulder Arthroplasty trials with a reported enrollment target (313% higher). The listed sponsor is Arthrex, which has 12 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Shoulder Arthroplasty appearing as the primary indexed condition, and to 0 interventions.

NCT03511586 reports 20 study locations spanning 15 distinct geographic areas - top geographies include Arizona, Florida, Michigan.

Frequently Asked Questions

What is clinical trial NCT03511586 about?

NCT03511586 is a clinical study titled "Total Shoulder Arthroplasty Multi-Center Registry". The objective of the study is a multi-center prospective registry to collect clinical outcomes of anatomic and reverse total shoulder arthroplasty.

What is the current status of trial NCT03511586?

This trial is currently recruiting. The enrollment target is 2,500 participants. The study started on 2015-07-28. Estimated completion is 2035-11.

What conditions does trial NCT03511586 study?

This clinical trial studies the following conditions: Shoulder Arthroplasty.

Who is sponsoring clinical trial NCT03511586?

This trial is sponsored by Arthrex, which has 12 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03511586 being conducted?

This trial has 20 study locations across Arizona, Colorado, Connecticut, Florida, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Shoulder Arthroplasty

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.